About Takara Bio
Takara Bio is a company based in Frankfurt (Germany) founded in 1925.. The company has 1,780 employees as of March 31, 2024. Takara Bio has completed 4 acquisitions, including Clontech, Curio Bioscience and Rubicon Genomics. Takara Bio operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BridgeBio, BeiGene and Advanced Accelerator Applications, among others.
- Headquarter Frankfurt, Germany
- Employees 1780 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Takara Bio Inc.
-
Annual Revenue
$286.97 M (USD)3.53as on Mar 31, 2024
-
Net Profit
$6.63 M (USD)-29.64as on Mar 31, 2024
-
EBITDA
$42.94 M (USD)-15.95as on Mar 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
1780
as on Mar 31, 2024
-
Investments & Acquisitions
Clontech
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Takara Bio
Takara Bio is a publicly listed company on the TSE with ticker symbol 4974 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Takara Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Takara Bio
Takara Bio has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Clontech, Curio Bioscience and Rubicon Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Spatial omics solutions are provided for discovery research.
|
2021 | ||||
|
Genomic tools are provided for resequencing, genotyping, and expression analysis.
|
2002 | ||||
|
Reagents and kits for pre-analytical amplification technologies are supplied.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Takara Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Takara Bio Comparisons
Competitors of Takara Bio
Takara Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BridgeBio, BeiGene and Advanced Accelerator Applications, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Takara Bio
Frequently Asked Questions about Takara Bio
When was Takara Bio founded?
Takara Bio was founded in 1925.
Where is Takara Bio located?
Takara Bio is headquartered in Frankfurt, Germany. It is registered at Frankfurt, Hesse, Germany.
How many employees does Takara Bio have?
As of Mar 31, 2024, the latest employee count at Takara Bio is 1,780.
What is the annual revenue of Takara Bio?
Annual revenue of Takara Bio is $286.97M as on Mar 31, 2024.
What does Takara Bio do?
Takara Bio was founded in 1925 and is headquartered in Frankfurt, Germany. Gene-based therapies are developed by the company, including HF10, an oncolytic herpes simplex virus strain for antitumor activity, MAGE-A4 antigen-specific TCR gene therapy targeting esophageal cancer with retroviral vectors, and MazF-modified T-cells for HIV RNA cleavage. Contract services are also provided to the industrial and agricultural sectors in the biotechnology field.
Who are the top competitors of Takara Bio?
Takara Bio's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Is Takara Bio publicly traded?
Yes, Takara Bio is publicly traded on TSE under the ticker symbol 4974.
How many acquisitions has Takara Bio made?
Takara Bio has made 4 acquisitions, including Clontech, Curio Bioscience, and Rubicon Genomics.
What is Takara Bio's ticker symbol?
The ticker symbol of Takara Bio is 4974 on TSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.